Neurobiology of Cocaine Addiction: Implications for New Pharmacotherapy

REFERENCES

• Kelley AE. Memory and addiction: shared neural circuitry and molecular mechanisms. Neuron. 2004;44:161–179.
   PubMed Web of Science ®Google Scholar
• Hyman SE, Malenka RC, Nestler EJ. Neural mechanisms of addiction: the role of reward-related learning and memory. Annu Rev Neurosci. 2006;29:565–598.
   PubMed Web of Science ®Google Scholar
• Seiden LS, Sabol KE, Ricuarte GA. Amphetamine: effects on catecholamine systems and behavior. Annu Rev Pharmacol Toxicol. 1993;33:639–677.
   PubMed Web of Science ®Google Scholar
• Bradberry CW. Acute and chronic dopamine dynamics in a nonhuman primate model of recreational cocaine use. J Neurosci. 2000;20:7109–7115.
   PubMed Web of Science ®Google Scholar
• Jay TM. Dopamine: a potential substrate for synaptic plasticity and memory mechanisms. Prog Neurobiol. 2003;69:375–390.
   PubMed Web of Science ®Google Scholar
• Schultz W. Predictive reward signal of dopamine neurons. Am J Physiol. 1998;80:1–27.
   Google Scholar
• Wise RA. Dopamine, learning and motivation. Nature Neuroscience Reviews. 2004;5:483–494.
   PubMed Web of Science ®Google Scholar
• Sofuoglu M., Kosten TR. Novel approaches to the treatment of cocaine addiction. CNS Drugs. 2005;19:13–25.
   PubMed Web of Science ®Google Scholar
• Lindsey KP, Wilcox KM, Votaw JR, , et al. Effects of dopamine transporter inhibitors on cocaine self-administration in rhesus monkeys: relationship to transporter occupancy determined by positron emission tomography neuroimaging. J Pharmacol Exp Ther. 2004;309:959–969.
   Google Scholar
• Vocci F, Ling W. Medications development: successes and challenges. Pharmacol Ther. 2005;108:94–108.
   PubMedGoogle Scholar
• van Nimwegen L, de Haan L, van Beveren N, van den Brink W, Linszen D. Adolescence, schizophrenia and drug abuse: a window of vulnerability. Acta Psychiatr Scand Suppl. 2005:35–42.
   Google Scholar
• Xi ZX, Newman AH, Gilbert JG, , et al. The novel dopamine D3 receptor antagonist NGB 2904 inhibits cocaine's rewarding effects and cocaine-induced reinstatement of drug-seeking behavior in rats. Neuropsychopharmacology. 2006;31:1393–1405.
   PubMed Web of Science ®Google Scholar
• Everitt BJ, Wolf ME. Psychomotor stimulant addiction: a neural systems perspective. J Neurosci. 2002;22:3312–3320.
   PubMed Web of Science ®Google Scholar
• Kalivas PW, Volkow ND. The neural basis of addiction: a pathology of motivation and choice. Am J Psychiatry. 2005;162:1403–1413.
   PubMed Web of Science ®Google Scholar
• Garavan H, Pankiewicz J, Bloom A, , et al. Cue-induced cocaine craving: neuroanatomical specificity for drug users and drug stimuli. Am J Psychiatry. 2000;157:1789–1798.
   PubMed Web of Science ®Google Scholar
• Vanderschuren LJ, Everitt BJ. Drug seeking becomes compulsive after prolonged cocaine self-administration. Science. 2004;305:1017–1019.
   PubMed Web of Science ®Google Scholar
• Kalivas PW, Volkow N, Seamans J. Unmanageable motivation in addiction: a pathology in prefrontal-accumbens glutamate transmission. Neuron. 2005;45:647–650.
   PubMed Web of Science ®Google Scholar
• Xi ZX, Ramamoorthy S, Shen H, Lake R, Samuvel DJ, Kalivas PW. GABA transmission in the nucleus accumbens is altered after withdrawal from repeated cocaine. J Neurosci. 2003;23:3498–3505.
   PubMedGoogle Scholar
• Tang XC, McFarland K, Cagle S, Kalivas PW. Cocaine-induced reinstatement requires endogenous stimulation of mu-opioid receptors in the ventral pallidum. J Neurosci. 2005;25:4512–4520.
   PubMed Web of Science ®Google Scholar
• McFarland K, Lapish CC, Kalivas PW. Prefrontal glutamate release into the core of the nucleus accumbens mediates cocaine-induced reinstatement of drug-seeking behavior. J Neurosci. 2003;23:3531–3537.
   PubMed Web of Science ®Google Scholar
• Toda S, Shen HW, Peters J, Cagle S, Kalivas PW. Cocaine increases actin cycling: effects in the reinstatement model of drug seeking. J Neurosci. 2006;26:1579–1587.
   PubMed Web of Science ®Google Scholar
• Yao WD, Gainetdinov RR, Arbuckle MI, , et al. Identification of PSD-95 as a regulator of dopamine-mediated synaptic and behavioral plasticity. Neuron. 2004;41:625–638.
   PubMed Web of Science ®Google Scholar
• Brebner K, Wong TP, Liu L, , et al. Nucleus accumbens long-term depression and the expression of behavioral sensitization. Science. 2005;310:1340–1343.
   Web of Science ®Google Scholar
• Peters J, Kalivas PW. The group II metabotropic glutamate receptor agonist, LY379268, inhibits both cocaine- and food-seeking behavior in rats. Psychopharmacology (Berl). 2006;186:143–149.
   Google Scholar
• Baptista MA, Martin-Fardon R, Weiss F. Preferential effects of the metabotropic glutamate 2/3 receptor agonist LY379268 on conditioned reinstatement versus primary reinforcement: comparison between cocaine and a potent conventional reinforcer. J Neurosci. 2004;24:4723–4727.
   PubMed Web of Science ®Google Scholar
• LaRowe S, Mardikan P, Malcolm R, , et al. Safety and tolerability of N-acetylcysteine in cocaine-dependent individuals. Am J Addict. 2005;15:105–110.
   Google Scholar
• Flanagan RJ, Meredith TJ. Use of N-acetylcysteine in clinical toxicology. Am J Med. 1991;91:131S–139S.
   PubMed Web of Science ®Google Scholar
• Baker DA, McFarland K, Lake RW, , et al. Neuroadaptations in cystine-glutamate exchange underlie cocaine relapse. Nat Neurosci. 2003;6:743–749.
   PubMed Web of Science ®Google Scholar
• Moran MM, McFarland K, Melendez RI, Kalivas PW, Seamans JK. Cystine/glutamate exchange regulates metabotropic glutamate receptor presynaptic inhibition of excitatory transmission and vulnerability to cocaine seeking. J Neurosci. 2005;25:6389–6393.
   PubMed Web of Science ®Google Scholar
• Goldstein RA, Volkow ND. Drug addiction and its underlying neurobiological basis: neuroimaging evidence for the involvement of the frontal cortex. Am J Psychiatry. 2002;159:1642–1652.
   PubMed Web of Science ®Google Scholar
• Ferraro L, Antonelli T, O'Connor WT, Tanganelli S, Rambert FA, Fuxe K. The effects of modafinil on striatal, pallidal and nigral GABA and glutamate release in the conscious rat: evidence for a preferential inhibition of striato-pallidal GABA transmission. Neurosci Lett. 1998;253:135–138.
   PubMed Web of Science ®Google Scholar
• Dackis CA, Kampman KM, Lynch KG, Pettinati HM, O'Brien CP. A double-blind, placebo-controlled trial of modafinil for cocaine dependence. Neuropsychopharmacology. 2005;30:205–211.
   PubMed Web of Science ®Google Scholar
• Ballon JS, Feifel D. A systematic review of modafinil: Potential clinical uses and mechanisms of action. J Clin Psychiatry. 2006;67:554–566.
   PubMed Web of Science ®Google Scholar
• Lynch G, Gall CM. Ampakines and the threefold path to cognitive enhancement. Trends Neurosci. 2006;29:554–562.
   PubMedGoogle Scholar
• Botreau F, Paolone G, Stewart J. d-Cycloserine facilitates extinction of a cocaine-induced conditioned place preference. Behavioral Brain Research. 2006;172:173–178.
   PubMed Web of Science ®Google Scholar
• Chiamulera C, Epping-Jordan M, Zocchi A, , et al. Reinforcing and locomotor stimulant effects of cocaine are absent in mGluR5 null mutant mice. Nat Neurosci. 2001;4:873–874.
   PubMed Web of Science ®Google Scholar
• McGeehan AJ, Olive MF. The mGluR5 antagonist MPEP reduces the conditioned rewarding effects of cocaine but not other drugs of abuse. Synapse. 2003;47:240–242.
   PubMed Web of Science ®Google Scholar
• Backstrom P, Hyytia P. Ionotropic and metabotropic glutamate receptor antagonism attenuates cue-induced cocaine seeking. Neuropsychopharmacology. 2006;31:778–786.
   PubMed Web of Science ®Google Scholar
• Caille S, Parsons LH. Intravenous heroin self-administration decreases GABA efflux in the ventral pallidum: an in vivo microdialysis study in rats. Eur J Neurosci. 2004;20:593–596.
   Google Scholar
• Zahm DS, Williams E, Wohltmann C. Ventral striatopallidothalamic projection: IV. Relative involvements of neurochemically distinct subterritories in the ventral pallidum and adjacent parts of the rostroventral forebrain. J Comp Neurol. 1996;364:340–362.
   PubMedGoogle Scholar
• Ling W, Shoptaw S, Majewska D. Baclofen as a cocaine anti-craving medication: a preliminary clinical study. Neuropsychopharmacology. 1998;18:403–404.
   PubMed Web of Science ®Google Scholar
• Brebner K, Childress AR, Roberts DC. A potential role for GABA(B) agonists in the treatment of psychostimulant addiction. Alcohol. 2002;37:478–484.
   Google Scholar
• Shoptaw S, Yang X, Rotheram-Fuller EJ, , et al. Randomized placebo-controlled trial of baclofen for cocaine dependence: preliminary effects for individuals with chronic patterns of cocaine use. J Clin Psychiatry. 2003;64:1440–1448.
   PubMed Web of Science ®Google Scholar
• Haney M, Hart CL, Foltin RW. Effects of baclofen on cocaine self-administration: opioid- and nonopioid-dependent volunteers. Neuropsychopharmacology. 2006;31:1814–1821.
   PubMed Web of Science ®Google Scholar
• Childress AR, Franklin T, Listerud J. Neuroimaging of cocaine craving states: Cessation, stimulant administration and drug cue paradigms. College on Problems of Drug Dependence: Proceedings of the 64th Annual Scientific Meeting Abstracts; 2002.
   Google Scholar
• O'Brien CP. Anticraving medications for relapse prevention: a possible new class of psychoactive medications. Am J Psychiatry. 2005;162:1423–1431.
   PubMed Web of Science ®Google Scholar
• Schmitz JM, Stotts AL, Sayre SL, DeLaune KA, Grabowski J. Treatment of cocaine-alcohol dependence with naltrexone and relapse prevention therapy. Am J Addict. 2004;13:333–341.
   PubMed Web of Science ®Google Scholar
• Schmitz JM, Stotts AL, Rhoades HM, Grabowski J. Naltrexone and relapse prevention treatment for cocaine-dependent patients. Addict Behav. 2001;26:167–180.
   PubMed Web of Science ®Google Scholar
• Sofuoglu M, Singha A, Kosten TR, McCance-Katz FE, Petrakis I, Oliveto A. Effects of naltrexone and isradipine, alone or in combination, on cocaine responses in humans. Pharmacol Biochem Behav. 2003;75:801–808.
   PubMed Web of Science ®Google Scholar
• Oslin DW, Pettinati HM, Volpicelli JR, Wolf AL, Kampman KM, O'Brien CP. The effects of naltrexone on alcohol and cocaine use in dually addicted patients. J Subst Abuse Treat. 1999;16:163–167.
   PubMed Web of Science ®Google Scholar
• Modesto-Lowe V, Burleson JA, Hersh D, Bauer LO, Kranzler HR. Effects of naltrexone on cue-elicited craving for alcohol and cocaine. Drug Alcohol Depend. 1997;49:9–16.
   PubMed Web of Science ®Google Scholar
• Hubert GW, Kuhar MJ. Colocalization of CART with substance P but not enkephalin in the rat nucleus accumbens. Brain Res. 2005;1050:8–14.
   Google Scholar
• Jaworski JN, Jones DC. The role of CART in the reward/reinforcing properties of psychostimulants. Peptides. 2006;27:1993–2004.
   Google Scholar
• Couceyro PR, Evans C, McKinzie A, , et al. Cocaine- and amphetamine-regulated transcript (CART) peptides modulate the locomotor and motivational properties of psychostimulants. J Pharmacol Exp Ther. 2005;315:1091–1100.
   Google Scholar
• Steiner RC, Hsiung HM, Picciotto MR. Cocaine self-administration and locomotor sensitization are not altered in CART knockout mice. Behav Brain Res. 2006;171:56–62.
   Google Scholar